Comparative effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction

被引：1
|
作者：
Bhatt, Ankeet S. [1 ,2 ,3 ]
Vaduganathan, Muthiah [4 ]
Jena, Barada Prasad [5 ]
Suminska, Sylwia [6 ]
Eid, Carlos [7 ]
Khairnar, Rahul [8 ]
Farries, Gabriella [6 ]
Senni, Michele [9 ]
机构：
[1] Kaiser Permanente San Francisco Med Ctr, San Francisco, CA USA
[2] Div Res, San Francisco, CA USA
[3] Stanford Univ, Sch Med, Div Cardiovasc Med, Palo Alto, CA USA
[4] Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA USA
[5] Novartis Global Serv Ctr, Hyderabad, India
[6] Novartis Corp Ctr, Dublin, Ireland
[7] Novartis Pharm Serv AG, Off Middle East & North Afr, Nairobi, Kenya
[8] Novartis Pharmaceut, E Hanover, NJ USA
[9] Univ Milano Bicocca, Osped Papa Giovanni XXIII, Bergamo, Italy
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷 / 05期
关键词：
D O I：
10.1002/ejhf.3233
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1172 / 1174
页数：3
相关论文
共 50 条
  • [21] Sacubitril/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction
    Fernandes, Amanda D. F.
    Fernandes, Gilson C.
    Ternes, Caique M. P.
    Cardoso, Rhanderson
    Chaparro, Sandra V.
    Goldberger, Jeffrey J.
    HEART RHYTHM O2, 2021, 2 (06): : 724 - 732
  • [22] Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction
    Park, Dae Yong
    An, Seokyung
    Attanasio, Steve
    Jolly, Neeraj
    Malhotra, Saurabh
    Doukky, Rami
    Samsky, Marc D.
    Sen, Sounok
    Ahmad, Tariq
    Nanna, Michael G.
    Vij, Aviral
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 187 : 84 - 92
  • [23] Comparison of the Efficacy and Safety of Sacubitril/Valsartan and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients With Reduced Ejection Fraction Combined With Moderate-to-Severe Chronic Kidney Disease
    Zhang, Zhaowei
    Chen, Shenjue
    Xu, Xuchun
    Luo, Guangwen
    Huang, Jian
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2024, 29
  • [24] COMPARATIVE EFFECTIVENESS OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN HEART FAILURE
    Sharma, M.
    Johnson, M. L.
    Chen, H.
    Aparasu, R.
    VALUE IN HEALTH, 2015, 18 (03) : A133 - A133
  • [25] Nurse-Led Titration of Angiotensin-Converting Enzyme Inhibitors, β-Adrenergic Blocking Agents, and Angiotensin Receptor Blockers in Patients With Heart Failure With Reduced Ejection Fraction
    Driscoll, Andrea
    Currey, Judy
    Tonkin, Andrew Maxwell
    JAMA CARDIOLOGY, 2016, 1 (07) : 842 - 843
  • [26] DAPAGLIFLOZIN VERSUS SACUBITRIL-VALSARTAN FOR HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION
    Arbel, Ronen
    Oberoi, Mansi
    Alnsasra, Hilmi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 628 - 628
  • [27] Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction
    Arbel, Ronen
    Azab, Abed N.
    Oberoi, Mansi
    Aboalhasan, Enis
    Star, Artyom
    Elhaj, Khaled
    Khalil, Fouad
    Alnsasra, Hilmi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [28] Targeting sacubitril/valsartan for heart failure with mildly reduced or preserved ejection fraction
    Greene, Stephen J.
    Fonarow, Gregg C.
    EUROPEAN HEART JOURNAL, 2023, 44 (31) : 2994 - 2997
  • [29] The Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Diabetes
    Padwal, Raj
    Lin, Mu
    Eurich, Dean T.
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (03): : 200 - 206
  • [30] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in heart failure patients with mid-range and preserved ejection fraction and clinical outcomes: from the KCHF Registry
    Yoshikawa, Y.
    Tamaki, Y.
    Yaku, H.
    Yamamoto, E.
    Ozasa, N.
    Inuzuka, Y.
    Morimoto, T.
    Kato, T.
    Kimura, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 328 - 328
12345